A Win For NovaBay Pharmaceuticals, Inc.
Thu, Sep 04, 2025 at 07:45 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) shot up at $4.22, representing a gain of 57.5%. On Thu, Sep 04, 2025, NBY:NYSEMKT hit a New 2-Week High of $4.22. The stock got featured on our News Catalysts scanner on Tue, Aug 26, 2025 at 04:51 PM in the 'INVESTOR UPDATE' category. From Thu, Aug 21, 2025, the stock recorded 66.67% Up Days and 70.00% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 3100%
- Concorde International Group Ltd. (CIGL:NASDAQ), 97.96%
- Inno Holdings Inc. (INHD:NASDAQ), 72.27%
- Brillia Inc (BRIA:NYSEMKT), 62.12%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 57.46%
- Duluth Holdings Inc. (DLTH:NASDAQ), 52.12%
- Hour Loop, Inc. (HOUR:NASDAQ), 48.82%
- Bolt Projects Holdings, Inc. (BSLK:NASDAQ), 47.06%
- HWH International Inc. (HWH:NASDAQ), 39.95%
- Super X AI Technology Ltd Ord (SUPX:NASDAQ), 39.2%